Subcutaneous administration of pembrolizumab: a paradigm shift toward patient-centered cancer care.

ABSTRACT:

SUBMITTER: Kobayashi N 

PROVIDER: S-EPMC12688599 | biostudies-literature | 2025 Nov

REPOSITORIES: biostudies-literature